Clinical Trial Update: HSPA12B as a Potential Biomarker for Sepsis and Severe Sepsis

View source ↗

Summary

A completed clinical trial evaluated HSPA12B as a biomarker for sepsis and severe sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Changhai Hospital | Conditions: Sepsis | Status: COMPLETED